Purchasers Seek Class Status In Ditropan Case

By Erin Coe (June 26, 2007, 12:00 AM EDT) -- Indirect purchasers of Ditropan XL are seeking class status in their antitrust action against Alza Corp. for allegedly blocking generic copycats of the bladder treatment from entering the U.S. market, less than a week after Alza urged the court to dismiss the case....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!